Is Osteopathic Manipulative Treatment (OMT) Beneficial for Elderly Patients Hospitalized With Pne… (NCT00258661) | Clinical Trial Compass
CompletedNot Applicable
Is Osteopathic Manipulative Treatment (OMT) Beneficial for Elderly Patients Hospitalized With Pneumonia?
United States406 participantsStarted 2004-03
Plain-language summary
Osteopathic Manipulative Treatment (OMT) were used in the 1800s and 1900s to treat pneumonia before the introduction of antibiotics in the mid-1900s. The purpose of this study is to determine if OMT, when used in conjunction with antibiotics and other usual care, will improve the recovery of elderly pneumonia patients.
Who can participate
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 50 Years old or older
* Subject is hospitalized in an acute care facility
* Subject must exhibit at least two of the classic symptoms of pneumonia, to include:
* Respiration Rate greater than or equal to 25 respirations per minute
* New or increased cough
* Fever greater than or equal to 100.4 degrees F (38 degrees C)
* Pleuritic chest pain
* Worsening of mental or functional status
* Leukocytosis (WBC greater than 12,000 cells per cubic millimeter)
* New or increased physical findings (rales, wheezing, bronchial breath sounds)
Exclusion Criteria:
* Lung abscess
* Advancing pulmonary fibrosis
* Bronchiectasis
* Pulmonary tuberculosis
* Lung Cancer
* Metastatic malignancy
* Uncontrolled metabolic bone disease that places subject at risk for pathologic bone fracture (i.e. Paget's Disease or hypoparathyroidism)
* Acute or unhealed rib or vertebral fracture
* History of pathologic bone fracture
* Previous participants as subject in the study
* Respiratory failure (intubation)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Length of Hospital Stay
Timeframe: End of hospital stay
2
Time to Clinical Stability
Timeframe: Daily for the duration of the hospital stay